Implementing Ocular Surface Disease Treatment Strategies For Today’s Cataract Patient
Colin Kerr
Published: Thursday, August 29, 2019
In this supplement, published by EuroTimes in association with the ESCRS/EuCornea Education Forum, we learn about how to implement ocular surface disease treatment strategies for today’s cataract patient. The supplement includes articles by José L. Güell, Spain; Béatrice Cochener-Lamard, France; José M. Benítez-del-Castillo, Spain; and Francesco Carones, Italy.
The supplement is supported by an unrestricted educational grant from Shire and Johnson&Johnson Vision.
Download Supplement - click here
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.